ENGINEERING PHARMACEUTICAL INNOVATION
ENGINEERING PHARMACEUTICAL INNOVATION
communities of practice
affiliates and chapters
career exchange
regulatory resources
publications
education and training
Professional Certification
join IPSE
Keyword Search:
  
Site Map
 
What our members say

There is always more than one way to do things and ISPE allows us to share these perspectives. We share information among Members from pharmaceutical companies, as well as among suppliers and regulators. That is how we work to best effect.

Guy Wingate, Ph.D.
GlaxoSmithKline, United Kingdom

Watch the Video:
True Stories: What it means to be an ISPE Member - (WMV, 16 MB) (Click to begin, or right-click to download and view later)

Papers
ISPE Qualification White Paper Addresses FDA Challenge

ISPE  has published a white paper, "Risk-Based Qualification for the 21st Century,"  to address the challenges of improving and streamlining qualification for cost and time savings, while meeting the new regulatory focus on process understanding and risk mitigation. Authored by a task team appointed by ISPE’s International Leadership Forum, the white paper is a direct response to the FDA’s request for the Society to be a "catalyst for change" in our industry. The FDA has recognized that qualification is an area whose main purpose is often lost: to ensure that equipment is fit for purpose. The FDA is emphasizing quality through systems of quality management, scientific application of process understanding, and controlling risks to the manufacturing process that could impact product quality. 

"" Risk-Based Qualification for the 21st Century white paper

For excellent guidance on how to build a focused qualification program, check out ISPE’s Commissioning and Qualification Baseline® Guide.

Sub ISPE image

© 2008 International Society for Pharmaceutical Engineering. All rights reserved.